US Patent Issued to Universiteit Gent on Feb. 24 for "Method for the in vitro differentiation and maturation of dendritic cells for therapeutic use" (Belgian Inventor)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,535, issued on Feb. 24, was assigned to Universiteit Gent (Ghent, Belgium).

"Method for the in vitro differentiation and maturation of dendritic cells for therapeutic use" was invented by Karim Vermaelen (Wondelgem, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an accelerated method to generate high yields of type-1 polarizing mRNA loaded dendritic cells for use in immunotherapy, and in particular for use in cancer vaccination."

The patent was filed on June 20, 2019, under Application No. 17/253,886.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi...